Medicare Enrolled
Dr. John Schaub, DO
Hematology & Oncology · Pensacola, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Schaub from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schaub?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Schaub
Dr. John Schaub is a hematology & oncology specialist in Pensacola, FL, with 10 years of NPI registration. Based on federal Medicare data, Dr. Schaub performed 141,277 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Schaub received a total of $6,777 from 63 pharmaceutical and/or device companies across 269 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schaub is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 10 years of NPI registration
▲ Top 4% volume in FL
$6,777 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Osteopathic Physician | 18579 | Clear | March 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗141,277
Medicare services
Top 4% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
19,620 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 19,200 | $43 | $131 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
18,360 | $0 | $6 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
12,850 | $2 | $21 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
11,550 | $0 | $6 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
11,501 | $0 | $14 |
| Nivolumab injection (Opdivo) | 9,060 | $24 | $74 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
8,600 | $0 | $36 |
| Paclitaxel chemotherapy injection | 7,550 | $0 | $1 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,660 | $0 | $3 |
| Anti-nausea injection (aprepitant) | 3,250 | $1 | $8 |
| Denosumab injection (Prolia/Xgeva) | 2,520 | $18 | $46 |
| Iron infusion (Monoferric) | 2,500 | $17 | $71 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,676 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,580 | $6 | $30 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,330 | $1 | $122 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
792 | $95 | $224 |
| Injection, granisetron hydrochloride, 100 mcg | 600 | $0 | $25 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
468 | $94 | $157 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
464 | $11 | $105 |
| Injection, leucovorin calcium, per 50 mg | 436 | $2 | $27 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
414 | $93 | $686 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
396 | $2 | $300 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
283 | $1 | $10 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
269 | $11 | $93 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
218 | $21 | $152 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
201 | $133 | $301 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
194 | $122 | $343 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
160 | $1 | $6 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
132 | $46 | $334 |
| Gadobenate dimeglumine injection Administration of gadobenate dimeglumine, a contrast agent used to enhance imaging results. |
130 | $1 | $16 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
118 | $132 | $412 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
116 | $7 | $462 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
107 | $46 | $304 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
105 | $20 | $156 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
101 | $1 | $5 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
73 | $52 | $205 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
67 | $4 | $26 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
56 | $42 | $281 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
55 | $15 | $97 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
55 | $67 | $148 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 55 | $401 | $638 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
54 | $1,166 | $4,120 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
45 | $93 | $232 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
35 | $61 | $157 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
32 | $25 | $249 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
30 | $26 | $141 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
30 | $2 | $19 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
26 | $90 | $1,005 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
26 | $18 | $111 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
24 | $9 | $91 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
24 | $1 | $19 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
21 | $202 | $1,400 |
| New patient office visit, complex (60-74 min) | 21 | $164 | $432 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
20 | $5 | $30 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
17 | $130 | $986 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
15.5% high complexity
83.4% medium
1.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,777
Total received (2018-2024)
Avg $968/year across 7 years
Top 42% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
269
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,346
2023
$981
2022
$1,120
2021
$1,533
2020
$832
2019
$876
2018
$90
Payments by company (2024)
Janssen Biotech, Inc.
$137
Novartis Pharmaceuticals Corporation
$132
Celgene Corporation
$112
E.R. Squibb & Sons, L.L.C.
$112
Medtronic, Inc.
$110
Regeneron Healthcare Solutions, Inc.
$98
Merck Sharp & Dohme LLC
$91
GENZYME CORPORATION
$91
AstraZeneca Pharmaceuticals LP
$75
Eisai Inc.
$61
Mirati Therapeutics, Inc.
$46
Genentech USA, Inc.
$38
Lilly USA, LLC
$38
Takeda Pharmaceuticals U.S.A., Inc.
$31
Alexion Pharmaceuticals, Inc.
$28
EMD Serono, Inc.
$23
Tempus AI, Inc
$21
Blueprint Medicines Corporation
$20
Pharmacosmos Therapeutics Inc.
$18
BeiGene USA, Inc.
$18
Genmab U.S., Inc.
$17
Astellas Pharma US Inc
$15
SpringWorks Therapeutics, Inc.
$13
Top 3 companies account for 28.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$586
BeiGene USA, Inc.
$383
Incyte Corporation
$372
Astellas Pharma US Inc
$368
E.R. Squibb & Sons, L.L.C.
$342
AstraZeneca Pharmaceuticals LP
$299
Genentech USA, Inc.
$291
Novartis Pharmaceuticals Corporation
$265
PFIZER INC.
$237
Merck Sharp & Dohme LLC
$224
Lilly USA, LLC
$221
GENZYME CORPORATION
$204
Eisai Inc.
$202
Seagen Inc.
$196
Janssen Biotech, Inc.
$181
Celgene Corporation
$167
Regeneron Healthcare Solutions, Inc.
$165
Allergan, Inc.
$125
Blueprint Medicines Corporation
$124
Teva Pharmaceuticals USA, Inc.
$124
Alexion Pharmaceuticals, Inc.
$119
Medtronic, Inc.
$110
Blue Earth Diagnostics Limited
$110
Ipsen Biopharmaceuticals, Inc
$90
EMD Serono, Inc.
$82
Mallinckrodt LLC
$79
Mirati Therapeutics, Inc.
$78
Takeda Pharmaceuticals U.S.A., Inc.
$75
Karyopharm Therapeutics Inc.
$74
AbbVie Inc.
$64
Rigel Pharmaceuticals, Inc.
$60
TESARO, Inc.
$53
GlaxoSmithKline, LLC.
$43
Stemline Therapeutics Inc.
$40
PUMA BIOTECHNOLOGY, INC.
$37
Kyowa Kirin, Inc.
$32
Foundation Medicine, Inc.
$32
ADC Therapeutics America, Inc.
$31
Merck Sharp & Dohme Corporation
$30
Acceleron Pharma, Inc.
$29
Helsinn Therapeutics (U.S.), Inc.
$28
MorphoSys, US Inc.
$27
Puma Biotechnology, Inc.
$25
SECURA BIO, INC.
$24
Daiichi Sankyo Inc.
$24
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$23
Bayer Healthcare Pharmaceuticals Inc.
$22
Tempus AI, Inc
$21
Adaptive Biotechnologies Corporation
$18
Pharmacosmos Therapeutics Inc.
$18
Epizyme, Inc.,
$18
Bayer HealthCare Pharmaceuticals Inc.
$18
Pharmacyclics LLC, an AbbVie Company
$18
Seattle Genetics, Inc.
$17
Genmab U.S., Inc.
$17
Pharmacyclics LLC, An AbbVie Company
$17
Alnylam Pharmaceuticals Inc.
$16
Deciphera Pharmaceuticals Inc.
$16
Taiho Oncology, Inc.
$15
AbbVie, Inc.
$14
SpringWorks Therapeutics, Inc.
$13
TerSera Therapeutics LLC
$12
Servier Pharmaceuticals LLC
$11
Top 3 companies account for 19.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AJOVY · ALIMTA · ALUNBRIG · AYVAKIT · BLENREP · BOSULIF · BRUKINSA · Blincyto · CABLIVI · CALQUENCE · CELLEXXTS PHOTOPHERESIS SYSTEM · COPIKTRA · CYRAMZA · Columvi · DARZALEX · ELIQUIS · ELITEK · ENJAYMO · ERLEADA · EVENITY · EXKIVITY · Enhertu · Epkinly · FARXIGA · FOUNDATIONONE · Fabhalta · GIVLAARI · HAWKONE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NERLYNX · NINLARO · Nerlynx · Nplate · Nubeqa · OGSIVEO · OPDIVO · OPDUALAG · Orserdu · PADCEV · PLUVICTO · POSLUMA · POTELIGEO · PREVYMIS · PROMACTA · Pomalyst · Prolia · QINLOCK · REBLOZYL · Reblozyl · Rituxan · SARCLISA · SOLIRIS · SOMATULINE DEPOT · Stivarga · TAGRISSO · TALVEY · TAZVERIK · TECENTRIQ · TIBSOVO · Tavalisse · Tecentriq · Ultomiris · VALCHLOR · VENCLEXTA · VERZENIO · VRAYLAR · Venclexta · XGEVA · XIFAXAN · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xtandi · ZEJULA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
20
County median income
$65,715
Nearest hospital to ZIP centroid (approximate)
BAPTIST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Schaub is a mixed practice specialist, with above-average Medicare volume (top 4% in FL).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Schaub experienced with filgrastim injection (nivestym) for white blood cells?
Based on Medicare claims data, Dr. Schaub performed 19,620 filgrastim injection (nivestym) for white blood cells services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Schaub receive payments from pharmaceutical companies?
Yes. Dr. Schaub received a total of $6,777 from 63 companies across 269 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schaub's costs compare to other hematology & oncology specialists in Pensacola?
Dr. Schaub's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schaub) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Pensacola
Browse hematology & oncology specialists in Pensacola ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology